Tepezza™ Transformation – Rodney’s Journey
On January 21, 2020, the U.S. Food and Drug Administration (FDA) approved Tepezza™ (teprotumumab-trbw) for the treatment of adults with Thyroid Eye Disease. This is a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis).